Recipharm and Adroit Science have formed a partnership that will see Adroit offering Recipharm solid state characterisation services.
The firms bring formulation development, API development, chemical analysis and solid state characterisation to the partnership, meaning that both speed and cost of development can be reduced.
“I am very excited about this collaboration”, said Carl-Johan Spak, Executive Vice President, Development & Technology at Recipharm. “With the addition of development services from Adroit, we will have a very competitive offering, which will help our customers to progress their projects in a highly efficient way. Adroit Science AB has fast established itself as one of the leading providers of solid state characterisation services in Northern Europe. Indeed, we can offer an even better service to our customers through this collaboration, including complete development from molecule to product.”
“Adroit Science and Recipharm have already cooperated in a number of successful projects, and this formal partnership marks the logical next step in the mutual development of our strategic relationship. We are delighted to join forces with a leading CDMO like Recipharm and predict that this will bring new opportunities in worldwide customer support” said Hans Gredeby, CEO of Adroit Science AB.